Guo, Y., Zhong, Y., Hu, P., Chen, Y., Guo, W., Chen, J., Guan, P., Zhou, Z., Zhu, F., Zeng, X., Gao, J., Xiong, Q., Yu, Z., Hu, C., Cai, Z., Xie, X., Hong, J. H., Chan, J. Y., Wang, W., Diao, D., Xia, X., Yu, Q., Ong, C. K., Gao, Y., Wu, X., Tan, J. (2026). Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer. Nature Communications. https://doi.org/10.1038/s41467-026-73805-7